X4 Pharmaceuticals, Inc.XFORNASDAQ
Loading
ROE: Strong ReturnsExpanding
Percentile Rank60
Studio
Year-over-Year Change

Return on equity

Latest
-42.51%
Near historical average
Percentile
P60
Within normal range
Streak
2 yr
Consecutive growthExpanding
Average
-43.55%
Historical baseline
PeriodValueYoY Change
2025-42.51%+74.9%
2024-169.08%+14.6%
2023-197.98%-56.2%
2022-126.76%+7.9%
2021-137.70%-61.3%
2020-85.35%-108.8%
2019-40.87%-114.3%
2018285.05%+594.0%
2017-57.71%-142.0%
2016137.38%-